Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) has earned a consensus rating of “Hold” from the twenty-two ...

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma ...

Zimmer Biomet's ZBH fourth-quarter 2025 performance was driven by its market expansion efforts. The company’s robust Knee business looks promising for growth. Meanwhile, a dull macroeconomic scenario ...

Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...

Zimmer Biomet Holdings, Inc. ZBH is participating ... about minimally invasive surgical techniques are expected to drive this growth. Additionally, a surge in sports injuries will contribute ...

at Zimmer Biomet," said Mr. Begley. "I and the entire Board of Directors are excited to see how he continues to drive even stronger value for patients, shareholders, physicians and customers in ...

Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...

Zimmer Biomet CEO Ivan Tornos said he anticipates ASCs to be a major support for growing orthopedic case volumes during the ...

The stock's fall snapped a five-day winning streak.

WARSAW, Ind., Feb. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Jehanzeb Noor is joining the Company as ...

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...